Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazo...

    2026-02-12

    MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Gold-Standard Tetrazolium Salt for In Vitro Cell Viability Assays

    Executive Summary: MTT is a cationic tetrazolium salt that enables quantitative, colorimetric measurement of cell viability and metabolic activity in mammalian cell cultures (Lv et al., 2021). Its reduction to purple formazan is tightly coupled to NADH-dependent oxidoreductase activity, reflecting mitochondrial and extra-mitochondrial metabolism. The assay's high sensitivity and direct readout make it a gold standard for cancer, neurobiology, and apoptosis research. APExBIO’s MTT (B7777) is supplied at ≥98% purity, ensuring reproducibility and specificity in research workflows (APExBIO product page). Quantitative results depend on proper solubilization, storage, and controls to avoid confounds from non-specific reduction or compound interference (see related).

    Biological Rationale

    MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is a small-molecule tetrazolium salt widely used to assess cell viability and metabolic activity in vitro (APExBIO). Its chemical structure enables membrane permeability, allowing direct access to intracellular reducing environments. The reduction of MTT is primarily catalyzed by NADH-dependent oxidoreductases localized to mitochondria, but extra-mitochondrial enzymes can also contribute (Lv et al., 2021). This reduction process reflects the functional status of living cells, providing a quantitative surrogate for proliferation and apoptosis. MTT is preferred over second-generation tetrazolium salts in many workflows due to its direct cell penetration and high sensitivity for mitochondrial activity (see annexin-v-biotin.com). This article extends prior overviews by integrating quantitative benchmarks and current best practices for translational research.

    Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

    MTT enters viable cells via passive diffusion due to its cationic nature and low molecular weight. Once inside, it is reduced by NADH- and NADPH-dependent oxidoreductase enzymes to yield insoluble purple formazan crystals (Lv et al., 2021). The primary site of reduction is the mitochondrial inner membrane, but cytosolic and plasma membrane enzymes may also contribute, especially in metabolically active or stressed cells. The amount of formazan formed is proportional to the number of metabolically active (viable) cells. Formazan is insoluble in aqueous solutions and must be solubilized (e.g., using DMSO) before absorbance quantification, typically at 570 nm. The reduction process is rapid (1–4 hours at 37°C) and is not observed in dead or fixed cells, making MTT highly specific for living cell populations. Unlike MTS or XTT, MTT does not require exogenous electron-coupling reagents due to its unique charge and structure (APExBIO).

    Evidence & Benchmarks

    • MTT reduction is tightly correlated with mitochondrial activity and cell viability in diverse human cell lines, including SK-N-SH and SK-N-BE, as shown in Parkinson’s disease models (Lv et al., 2021).
    • Downregulation of lncRNA MALAT1 by siRNA in MPP+-stimulated neuronal cells increases MTT reduction signal, consistent with enhanced cell proliferation and reduced apoptosis (Lv et al., 2021).
    • MTT formazan solubility is ≥41.4 mg/mL in DMSO and ≥18.63 mg/mL in ethanol; incomplete dissolution leads to underestimation of viable cell counts (APExBIO).
    • The APExBIO MTT (B7777) product achieves ≥98% purity, minimizing background and increasing assay reproducibility (APExBIO).
    • In controlled experiments, MTT signal is abolished in fixed or heat-killed cells, confirming specificity for viable, metabolically active populations (mito-mscarlet.com).
    • MTT is compatible with most standard cell culture media and formats, but interference from reducing agents or colored compounds should be controlled (annexin-v-fitc.com).

    Applications, Limits & Misconceptions

    MTT is widely used for quantifying cell proliferation, viability, and cytotoxicity in cancer, neurobiology, and drug screening assays. In Lv et al. (2021), MTT was used to quantify neuronal cell viability in Parkinson’s disease models after genetic and pharmacological manipulation. The assay is also employed to screen chemotherapeutic agents, investigate apoptosis, and evaluate metabolic function in diverse cell types (avacopanchems.com). This article updates prior guides by providing current benchmarks for assay performance and troubleshooting.

    Common Pitfalls or Misconceptions

    • MTT does not directly measure cell number: It quantifies metabolic activity, which may change independently of cell number in some contexts.
    • Formazan must be fully solubilized: Incomplete dissolution leads to inaccurate absorbance readings.
    • Color interference: Colored compounds or high phenol red content in media can confound absorbance measurements.
    • Reductant interference: Exogenous antioxidants or reducing agents can artificially increase formazan production.
    • Assay is not suitable for non-adherent cells without optimization: Suspension cultures may require centrifugation or modified protocols.

    Workflow Integration & Parameters

    Preparation: APExBIO MTT (B7777) should be stored at -20°C to maintain stability. Working solutions must be freshly prepared and used within hours to avoid degradation (APExBIO). MTT is readily dissolved in DMSO (≥41.4 mg/mL) and ethanol (≥18.63 mg/mL); water solubility (≥2.5 mg/mL) requires ultrasonic treatment.

    Assay Parameters: Typical concentrations for cell-based assays are 0.2–0.5 mg/mL MTT, incubated for 1–4 hours at 37°C. After incubation, medium is removed and formazan is solubilized in DMSO or ethanol. Absorbance is measured at 570 nm with a reference at 630–690 nm to correct background. Controls for dead cells, media blanks, and color interference are required. For detailed troubleshooting and advanced applications, see promegestonemed.com, which focuses on the microenvironment and new research frontiers. This article clarifies the mechanistic basis and practical setup for maximum assay reliability.

    Integration: MTT can be multiplexed with other cell viability or apoptosis markers—e.g., annexin V or caspase assays—for orthogonal validation (annexin-v-fitc.com). This article extends workflow recommendations to highlight parameter ranges and integration strategies not covered in previous summaries.

    Conclusion & Outlook

    MTT remains a gold-standard colorimetric cell viability assay owing to its direct correlation with mitochondrial metabolic activity, high sensitivity, and reproducibility across diverse cell types and experimental conditions (Lv et al., 2021). APExBIO’s B7777 reagent delivers consistent purity and performance, supporting robust in vitro research from cancer biology to neurodegeneration. With proper controls and workflow integration, MTT assays provide quantitative, actionable data for drug screening, mechanistic studies, and translational applications. For advanced assay design, see mito-mscarlet.com, which explores next-generation approaches for metabolic activity measurement. This article provides current best practices, quantitative benchmarks, and clarifies misconceptions for researchers seeking reliable in vitro cell proliferation assay reagents.